Биохимические измерения новорожденных Гипоксия

Overview

This study describes a method for measuring biochemical markers of neonatal hypoxia-ischemia. The approach involves collecting blood samples from infants and analyzing plasma for specific metabolites using HPLC and GC/MS techniques.

Key Study Components

Area of Science

• Neonatal medicine
• Biochemistry
• Metabolomics

Background

• Neonatal hypoxia-ischemia can lead to significant health issues.
• Measuring biochemical markers is crucial for early diagnosis.
• High pressure liquid chromatography (HPLC) and Gas Chromatography Mass Spectrometry (GC/MS) are effective analytical techniques.
• Understanding metabolite concentrations can inform treatment strategies.

Purpose of Study

• To measure hypoxanthine, xanthine, and uric acid concentrations in plasma.
• To analyze allantoin concentration and MDA levels.
• To assess xanthine oxidase activity in neonates.

Methods Used

• Blood samples collected from infants.
• Plasma isolation and filtration.
• Analysis of metabolites using HPLC and GC/MS.
• Enzymatic reaction initiation and quenching for xanthine oxidase activity measurement.

Main Results

• Successful measurement of hypoxanthine, xanthine, and uric acid concentrations.
• Allantoin and MDA levels were accurately quantified.
• Xanthine oxidase activity was determined using HPLC.
• Findings contribute to understanding neonatal hypoxia-ischemia.

Conclusions

• The methods described are effective for analyzing biochemical markers.
• Results can aid in the diagnosis and management of neonatal conditions.
• Further research is needed to explore clinical implications.

Frequently Asked Questions